Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Paraphrase, not own words

Rules 1.1.0 · as of 14 Sep 2026

Quote

Paraphrase, not own words

“Lykos is currently renegotiating with Trump's new FDA regime in hopes of a reversal of last year's rejection. If this approach fails, Lykos will likely have to redo their Phase 3 studies which will set approval back by at least 3 years.”
· Lykos founder Rick Doblin on Joe Rogan (Xeia VP summary of JRE #2319) · podcast

If FDA renegotiation fails, a new Phase 3 delays MDMA approval by at least three years (to 2028+).

The only record of the claim is a third party's paraphrase or a secondhand report; the forecaster's own words are not available. Shown as a row, never coded or scored.